|
|
|
Insider
Information: |
Hecht Peter M |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,594,751 |
|
Indirect Shares
|
14,622 |
|
|
Direct
Value |
$14,152,430 |
|
|
Indirect Value
|
$92,406 |
|
|
Total
Shares |
2,609,373 |
|
|
Total
Value |
$14,244,836 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
Percentage
Gain/Loss : |
-53.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ironwood Pharmaceuticals Inc |
IRWD |
Chief Executive Office... |
2019-03-05 |
2,217,366 |
2019-03-05 |
14,550 |
Premium* |
|
Cyclerion Therapeutics, Inc. |
CYCN |
|
2024-01-01 |
377,385 |
2024-01-01 |
72 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
223,192 |
223,192 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2019-04-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
221,736 |
221,736 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2019-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,455 |
485 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2019-07-10 |
4 |
OE |
$6.04 |
$12,080 |
D/D |
2,000 |
225,192 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2021-05-04 |
4 |
B |
$2.29 |
$687,000 |
D/D |
300,000 |
524,527 |
0.01 |
% |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2021-05-05 |
4 |
B |
$2.53 |
$1,006,943 |
D/D |
398,001 |
922,528 |
0.01 |
% |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2021-05-06 |
4 |
B |
$2.43 |
$733,860 |
D/D |
302,000 |
1,224,528 |
0.01 |
% |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2021-06-03 |
4 |
B |
$3.28 |
$2,699,998 |
D/D |
823,170 |
2,047,698 |
0.01 |
% |
|
CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
|
2023-05-19 |
4 |
A |
$8.68 |
$1,953,000 |
D/D |
225,000 |
327,385 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
|
|
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
347,385 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
|
|
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
362,385 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
|
|
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
377,385 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive OfficerOfficer |
|
2010-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,499,751 |
|
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2010-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,359 |
19,359 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2010-10-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,465 |
1,155 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2010-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,210 |
21,569 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2010-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,234 |
22,803 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2011-05-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,580 |
2,015 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2012-04-05 |
4 |
OE |
$0.41 |
$61,500 |
D/D |
150,000 |
3,649,751 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2012-07-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,940 |
2,985 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2012-08-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
970 |
2,985 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2012-11-05 |
4 |
B |
$11.65 |
$582,500 |
D/D |
50,000 |
72,803 |
2.81 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2013-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
615 |
73,418 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2013-04-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,385 |
3,780 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
|
2013-07-08 |
4 |
OE |
$0.60 |
$60,000 |
D/D |
100,000 |
3,749,751 |
0 |
- |
|
63 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|